DUBLIN--(BUSINESS WIRE)--The "Global Prader-Willi Syndrome Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering. This report provides most up-to-date ...
Haley Kavrell, 17, who must cope with Prader-Willi syndrome, which causes her to feel constant hunger, picks basil at her home in Davis late last month. Renée C. Byer [email protected] After receiving ...
MINNEAPOLIS (WCCO) --No parent wants their child to suffer from hunger pains, but for one Twin Cities family, that's a constant struggle. Two-year-old Nick Joncas never feels full. He has a disease ...
The European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) submitted by Soleno Therapeutics for diazoxide choline prolonged-release tablets, aimed at treating ...
Please provide your email address to receive an email when new articles are posted on . The FDA’s Division of Psychiatry has rejected a new drug application for treating hyperphagia, anxiousness and ...
The Prader-Willi Syndrome Association USA estimates that PWS occurs in one in every 15,000 live births. The hallmark symptom of this disorder is hyperphagia, a chronic and life-threatening condition ...
JACKSON, MI -- Organizers are hoping about 200 members of the community gather at Cascade Falls Park on Saturday to take part in the annual Prader-Willi Syndrome Association of Michigan awareness walk ...
Prader–Willi syndrome (PWS; OMIM #176270) is an imprinted neurobehavioral condition affecting many organ systems. Major manifestations include early childhood obesity, hyperphagia, hypotonia with poor ...
SARASOTA, Fla.--(BUSINESS WIRE)--April 23, 2004--Obesity has fast become a public health crisis in America. According to estimates from the Centers for Disease Control and Prevention, 64 percent of ...
Tania Markovic MBBS PhD FRACP; Jennifer L. Miller, MD; Elizabeth Roof, H.S.P., M.A.; and Theresa V. Strong, PhD; ...
A small study suggests that bariatric surgery did not result in long-term, sustainable weight loss or a reduction in comorbidities for adults with Prader-Willi syndrome despite early weight loss, ...
REDWOOD CITY, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback